Corcept Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Alaunos Therapeutics USD -755000 395K 2024-12
ANI Pharmaceuticals USD 26.19M 30.57M 2025-03
Ardelyx USD 8.12M 5.89M 2024-12
Aurora Cannabis CAD 36.22M 38.61M 2024-12
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 3.42M 21.85M 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
J&J USD 13.63B 9.74B 2025-03
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novartis USD 3.4B 193M 2024-12
Pacira USD 1.99M 22.71M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12



Corcept Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.